Apuli Maricel 4

What Happened
Apuli Maricel, Chief Accounting Officer of BridgeBio (BBIO), sold 2,000 shares on 2026-02-26 at $66.00 per share for total gross proceeds of $132,000. The transaction is reported as a sale (code S) and was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 8, 2025.

Key Details

• Transaction date and price: 2026-02-26 — 2,000 shares at $66.00/share (proceeds $132,000).
• Transaction type: S = Sale (open market or private sale indicated).
• Filing: Form 4 filed 2026-02-27 for period 2026-02-26 (appears timely).
• Shares owned after transaction: Not specified in the provided summary — check the full Form 4 for "Amount of Securities Owned Following Reported Transaction."
• Footnote: F1 — sale executed under a Rule 10b5-1 sales plan adopted 09/08/2025.

Context
A Rule 10b5-1 plan lets insiders schedule trades in advance and is commonly used to avoid trading on nonpublic information; sales under such plans can be routine and do not necessarily indicate a change in the insider’s view of the company. For retail investors, single scheduled sales are less informative than patterns of multiple or large sales (or insider purchases), so consider monitoring future filings for trends.